Drug Profile
DT 5461
Alternative Names: LA 15 PPLatest Information Update: 20 Dec 2000
Price :
$50
*
At a glance
- Originator Daiichi Pharmaceutical
- Class Antibacterials; Antineoplastics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 20 Dec 2000 Discontinued-Preclinical for Cancer in Japan (Injection)